Use access key #2 to skip to page content.
$13.50 0.03 (0.22%)
5/22/2008 3:42 PM

Boston Scientific Corp. (BSX)

CAPS Rating:
***

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

View All Commentary (BSX)

Recs

0

Avatar Richthofen80 (72.12) Submitted: 4/24/08 11:36 AM : Outperform Start Price: $12.53 BSX Score: 6.77

This stock is still going to go down before it goes up. However, it has the talent to succeed in 2+ years and recently cut the bloated and ineffective middle-management. Internationally poised well. Once it clears the debt hurdle and re-focuses on its own internal R&D, the stock will triple as demand soars for cardiology equipment due to baby boomer health issues.

Report this Post Replies: 0 | Reply

Featured Broker Partners